Different Th1, Th2, Th17 and Treg associated chemokine local pattern expression in lung in a murine model of allergic inflammation Source: Annual Congress 2011 - T-cell subsets Year: 2011
Modified mRNA encoding Foxp3 protects against allergic asthma in mice by rebalancing T helper cell responses through an IL-23 / IL-17A-dependent mechanism Source: Annual Congress 2012 - Treating childhood asthma Year: 2012
Interferon-γ-pretreated dendritic cells induced dual Th1 and Th2 responses and failed to prevent development of allergic airway inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006
Activin-A induces human regulatory T cells that control allergic asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
High-level expression of PD-L2 molecules by dendritic cells suppressed the Th2 response in allergic mouse Source: Eur Respir J 2007; 30: Suppl. 51, 368s Year: 2007
CD39/CD73 and the imbalance of Th17 and Tregs (regulatory T cells) in allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013
ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021
IL-10 produced by CD4+ T cells is essential for the development of airway hyperresponsiveness via suppression of endogenous IL-12 Source: Eur Respir J 2005; 26: Suppl. 49, 24s Year: 2005
Fevipiprant is superior to montelukast in suppressing type 2 cytokine production from mast cell stimulated human Th2 cells Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019
Regulatory role of antigen-induced IL-10, produced by Tr1 cells, in airway neutrophilia in a murine model for asthma Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018
Enhanced expression of IL-18 and increased CD8+ T cells and eosinophils in the airways of asthma death Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010
Adoptive transfer of T-helper cell type 1 clones attenuates an asthmatic phenotype in mice Source: Eur Respir J 2005; 25: 653-659 Year: 2005
CD38 gene-modified dendritic cells inhibit murine asthma development through increasing IL-12 production and promoting Th1 cell differentiation Source: International Congress 2016 – Immune responses in the lung Year: 2016
Macrophages induce an allergen-specific and long-term suppression in a mouse asthma model Source: Eur Respir J 2005; 26: 1040-1046 Year: 2005
Budesonide induces cell apoptosis, increases foxp3 expression, and reduces icos expression in T cell subpopulations of asthmatics Source: Annual Congress 2009 - Inflammatory cells and cytokines Year: 2009
Study of the effect of IL-4 and IFN-γ on Th1/Th2 cells and mast cells in allergic asthma patients Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
Bronchial epithelial cells from COPD patients overproduce an upstream Th2 regulator cytokine in response to viral stimuli Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009
IL-15 transpresentation in circulating progenitors of NK cells controls their differentiation potential, STAT6 activation and IL-13 production Source: Annual Congress 2005 - Regulation of the allergic and asthmatic response Year: 2005